ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Lee's Pharmaceutical Limited clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 80 studies whose lead sponsor is Lee's Pharmaceutical Limited or one of 2 companies grouped under it. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 3, 2026.

Our grouping of 3 registry names, not the registry’s. See them and correct one ↓

Pipeline: 2 programs

Each counted once: 2 with a study Lee's Pharmaceutical Limited leads registered in the last two years.

  • Phase 1
  • Phase 2

The 2 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Lee's Pharmaceutical Limited’s own registered studies; Lee's Pharmaceutical Limited’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Lee's Pharmaceutical Limited’s studies test, most open studies first — 29 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 19 more

Coming up

1 of Lee's Pharmaceutical Limited’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. 1S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

All 80 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now68%Recruiting 5 · Not yet recruiting 1
  • Completed3645%
  • Stopped early23%Suspended 1 · Withdrawn 1
  • Status unknown or other3645%

Phase

  • Phase 133
  • Phase 323
  • Phase 221
  • Phase 47

Where

  • China55
  • Hong Kong6

Over the years

  1. 08
  2. 09
  3. 10
  4. 11
  5. 12
  6. 13
  7. 14
  8. 15
  9. 16
  10. 17
  11. 1418
  12. 19
  13. 20
  14. 21
  15. 22
  16. 23
  17. 24
  18. 25
  19. 126

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Lee's Pharmaceutical Limited.

  • Lee's Pharmaceutical Limited
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    74 studies
  • Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
    Divested — left Lee's Pharmaceutical Limited, Oct 2020 · 11 more first submitted after it left, not counted · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited
    Divested — left Lee's Pharmaceutical Limited, Oct 2020 · 1 more first submitted after it left, not counted · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    0 studies →

Studies

Recruiting first, then most recently updated. Showing 50 of 80. Browse all 80 →